First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Sees Large Volume Increase – What’s Next?

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) saw unusually-strong trading volume on Friday . Approximately 17,007 shares traded hands during trading, a decline of 37% from the previous session’s volume of 27,022 shares.The stock last traded at $175.87 and had previously closed at $173.75.

First Trust NYSE Arca Biotechnology Index Fund Stock Performance

The stock has a market capitalization of $1.32 billion, a P/E ratio of 17.20 and a beta of 0.86. The firm has a 50-day moving average price of $171.57 and a 200 day moving average price of $164.94.

Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund

Hedge funds and other institutional investors have recently modified their holdings of the stock. Maia Wealth LLC raised its holdings in First Trust NYSE Arca Biotechnology Index Fund by 1.3% during the 3rd quarter. Maia Wealth LLC now owns 4,725 shares of the company’s stock valued at $795,000 after buying an additional 60 shares during the last quarter. Gateway Wealth Partners LLC raised its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 3.8% during the second quarter. Gateway Wealth Partners LLC now owns 1,656 shares of the company’s stock valued at $255,000 after acquiring an additional 61 shares during the last quarter. WealthShield Partners LLC boosted its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 1.8% during the second quarter. WealthShield Partners LLC now owns 3,714 shares of the company’s stock worth $572,000 after purchasing an additional 66 shares during the period. TD Capital Management LLC raised its position in First Trust NYSE Arca Biotechnology Index Fund by 6.4% during the 2nd quarter. TD Capital Management LLC now owns 1,141 shares of the company’s stock valued at $176,000 after purchasing an additional 69 shares during the last quarter. Finally, MML Investors Services LLC raised its position in First Trust NYSE Arca Biotechnology Index Fund by 2.2% during the 3rd quarter. MML Investors Services LLC now owns 3,888 shares of the company’s stock valued at $669,000 after purchasing an additional 84 shares during the last quarter.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.